Aseptic Filling Robotics, Injectable Advancements, & Sterile Manufacturing

Vanrx Pharmasystems will be showcasing new advancements in aseptic filling robotics and machine vision at INTERPHEX 2016.

Robotics and machine vision are core technologies in the SA25 Aseptic Workcell, a gloveless isolator for automated filling of injectable or lyophilized therapies. The SA25 fills syringes, vials and cartridges. Carlos Diaz, Vanrx’s machine vision leader, will be providing demonstrations of the SA25’s vision system, which guides robotic actions and supports the SA25’s process control.

“Vanrx comes to Interphex with growing acceptance of its SA25 Aseptic Workcell, which helps the industry modernize fill-finish operations for next-generation therapies,” says Chris Procyshyn, CEO, Vanrx Pharmasystems.

The SA25 is well-suited for the targeted, smaller volume therapies.

The Vanrx’s management team will be delivering three educational sessions on April 27 at INTERPHEX:

“Revolutionizing the Production of Injectable Medicines: A Simple Solution for a Complex Process”

Chris Procyshyn, CEO
Location: Technical conference stage 2 (Booth 1277) in the Exhibit Hall
Time: Wednesday, April 27, from 1:15-2:00 pm

“Addressing Sterile Manufacturing Challenges”

Chris Procyshyn, CEO will co-present with Matrix Alliance partners Daikyo Seiko and Schott as part of the Keynote Series, jointly presented by the Parenteral Drug Association (PDA) and Pharmaceutical Technology
Location: Javits Conventions Center, Interphex Innovation Stage
Time: Wednesday, April 27, from 3:30-5:00 pm

“Taking a Page from Semiconductors – How Other Industries’ Technology Can Inspire Improvement of Pharmaceutical Manufacturing Today”